• Letter or Testimony
  • May 23, 2018

CHA Comments on Proposed Delay to 340B Ceiling Price and Manufacturer Civil Monetary Penalties Regulation

On May 22, CHA joined the 340B Coalition and allied hospital groups and submitted joint comments in response to the Department of Health and Human Services’ (HHS) proposed delay of the 340B Drug Pricing Program (340B) Ceiling Price and Manufacturer Civil Monetary Penalties Regulation (Final Rule). The proposed rule would further delay the effective date of the Final Rule from July 1, 2018, to July 1, 2019. The comments urged HHS to implement the Final Rule immediately to ensure that pharmaceutical manufacturers comply with 340B requirements.